RATIONALE: Adverse social experience in adolescence causes reduced medial prefrontal cortex (mPFC) dopamine (DA) and associated behavioral deficits in early adulthood. OBJECTIVE: This study aims to determine whether mPFC DA hypofunction following social stress is specific to adolescent experience and if this results from stress-induced DA D2 receptor activation. MATERIALS AND METHODS: Male rats exposed to repeated social defeat during adolescence or adulthood had mPFC DA activity sampled 17 days later. Separate experiments used freely moving microdialysis to measure mPFC DA release in response to adolescent defeat exposure. At P40, 49 and 56 mPFC DA turnover was assessed to identify when DA activity decreased in relation to the adolescent defeat experience. Finally, nondefeated adolescent rats received repeated intra-mPFC infusions of the D2 receptor agonist quinpirole, while another adolescent group received intra-mPFC infusions of the D2 antagonist amisulpride before defeat exposure. RESULTS: Long-term decreases or increases in mPFC DA turnover were observed following adolescent or adult defeat, respectively. Adolescent defeat exposure elicits sustained increases in mPFC DA release, and DA turnover remains elevated beyond the stress experience before declining to levels below normal at P56. Activation of mPFC D2 receptors in nondefeated adolescents decreases DA activity in a similar manner to that caused by adolescent defeat, while defeat-induced reductions in mPFC DA activity are prevented by D2 receptor blockade. CONCLUSIONS: Both the developing and mature PFC DA systems are vulnerable to social stress, but only adolescent defeat causes DA hypofunction. This appears to result in part from stress-induced activation of mPFC D2 autoreceptors.
RATIONALE: Adverse social experience in adolescence causes reduced medial prefrontal cortex (mPFC) dopamine (DA) and associated behavioral deficits in early adulthood. OBJECTIVE: This study aims to determine whether mPFCDAhypofunction following social stress is specific to adolescent experience and if this results from stress-induced DA D2 receptor activation. MATERIALS AND METHODS: Male rats exposed to repeated social defeat during adolescence or adulthood had mPFCDA activity sampled 17 days later. Separate experiments used freely moving microdialysis to measure mPFCDA release in response to adolescent defeat exposure. At P40, 49 and 56 mPFCDA turnover was assessed to identify when DA activity decreased in relation to the adolescent defeat experience. Finally, nondefeated adolescent rats received repeated intra-mPFC infusions of the D2 receptor agonist quinpirole, while another adolescent group received intra-mPFC infusions of the D2 antagonist amisulpride before defeat exposure. RESULTS: Long-term decreases or increases in mPFCDA turnover were observed following adolescent or adult defeat, respectively. Adolescent defeat exposure elicits sustained increases in mPFCDA release, and DA turnover remains elevated beyond the stress experience before declining to levels below normal at P56. Activation of mPFC D2 receptors in nondefeated adolescents decreases DA activity in a similar manner to that caused by adolescent defeat, while defeat-induced reductions in mPFCDA activity are prevented by D2 receptor blockade. CONCLUSIONS: Both the developing and mature PFCDA systems are vulnerable to social stress, but only adolescent defeat causes DAhypofunction. This appears to result in part from stress-induced activation of mPFC D2 autoreceptors.
Authors: Sheila Shanmugan; Wen Cao; Theodore D Satterthwaite; Mary D Sammel; Arian Ashourvan; Danielle S Bassett; Kosha Ruparel; Ruben C Gur; C Neill Epperson; James Loughead Journal: Psychoneuroendocrinology Date: 2020-05-19 Impact factor: 4.905
Authors: Andrew M Novick; Mackenzie Mears; Gina L Forster; Yanlin Lei; Shanaz M Tejani-Butt; Michael J Watt Journal: Behav Brain Res Date: 2016-02-10 Impact factor: 3.332
Authors: Sandra Montagud-Romero; Cristina Nuñez; M Carmen Blanco-Gandia; Elena Martínez-Laorden; María A Aguilar; Javier Navarro-Zaragoza; Pilar Almela; Maria-Victoria Milanés; María-Luisa Laorden; José Miñarro; Marta Rodríguez-Arias Journal: Psychopharmacology (Berl) Date: 2017-05-02 Impact factor: 4.530
Authors: Michael J Watt; Matthew A Weber; Shaydel R Davies; Gina L Forster Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2017-06-19 Impact factor: 5.067
Authors: Matthew A Weber; Eric T Graack; Jamie L Scholl; Kenneth J Renner; Gina L Forster; Michael J Watt Journal: Eur J Neurosci Date: 2018-07-10 Impact factor: 3.386
Authors: Andrew M Novick; Gina L Forster; James E Hassell; Daniel R Davies; Jamie L Scholl; Kenneth J Renner; Michael J Watt Journal: Neuropharmacology Date: 2015-06-06 Impact factor: 5.250